SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PASQUINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.953
AS - Asia 2.200
EU - Europa 993
SA - Sud America 446
AF - Africa 64
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.667
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.839
SG - Singapore 828
CN - Cina 433
IT - Italia 384
BR - Brasile 365
VN - Vietnam 284
HK - Hong Kong 188
DE - Germania 130
GB - Regno Unito 87
FR - Francia 84
TR - Turchia 67
CA - Canada 65
JP - Giappone 64
BD - Bangladesh 63
IN - India 63
ID - Indonesia 61
RU - Federazione Russa 53
FI - Finlandia 45
PL - Polonia 45
UA - Ucraina 36
AR - Argentina 32
MX - Messico 32
NL - Olanda 24
ZA - Sudafrica 24
SE - Svezia 21
TW - Taiwan 19
PK - Pakistan 18
IQ - Iraq 16
CH - Svizzera 15
ES - Italia 15
CO - Colombia 13
MA - Marocco 13
MY - Malesia 13
SA - Arabia Saudita 12
EC - Ecuador 11
AT - Austria 10
KE - Kenya 10
KR - Corea 10
LT - Lituania 10
UZ - Uzbekistan 9
AU - Australia 8
VE - Venezuela 8
BE - Belgio 7
TN - Tunisia 7
PH - Filippine 6
BH - Bahrain 5
IR - Iran 5
JO - Giordania 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EG - Egitto 4
IL - Israele 4
PT - Portogallo 4
CZ - Repubblica Ceca 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
UY - Uruguay 3
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IE - Irlanda 2
JM - Giamaica 2
KG - Kirghizistan 2
PE - Perù 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MR - Mauritania 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
Totale 6.663
Salva come PNG Salva come JPEG
Città #
Ashburn 522
Singapore 510
San Jose 248
Hong Kong 184
Fairfield 166
Beijing 157
Santa Clara 156
Council Bluffs 107
Woodbridge 107
Chandler 104
Los Angeles 97
Ho Chi Minh City 96
Houston 91
Ferrara 87
New York 79
Seattle 73
Hanoi 66
Munich 61
Tokyo 59
Cambridge 55
Jakarta 53
Dallas 48
Lauterbourg 48
Wilmington 48
Milan 43
Warsaw 41
Ann Arbor 37
São Paulo 37
Orem 33
Shanghai 33
Jacksonville 29
Buffalo 28
Izmir 28
Bologna 27
Princeton 27
Denver 25
Chennai 22
London 22
Chicago 20
Toronto 20
Montreal 19
Turku 18
Frankfurt am Main 17
Mexico City 16
Hefei 15
Helsinki 15
Rio de Janeiro 15
Zurich 15
Da Nang 14
Taipei 14
Manchester 13
Atlanta 12
Johannesburg 12
Poplar 12
Boston 11
Brooklyn 11
Haiphong 11
Nanjing 11
Nuremberg 11
Phoenix 11
San Francisco 11
Ankara 10
Rome 10
San Diego 10
Venice 10
Boardman 9
Falls Church 9
Kuala Lumpur 9
Moscow 9
Tucson 9
Vercelli 9
Ferrara di Monte Baldo 8
Florence 8
Istanbul 8
Nice 8
Tashkent 8
Belo Horizonte 7
Curitiba 7
Nairobi 7
Salt Lake City 7
Salvador 7
San Antonio 7
Stockholm 7
Baghdad 6
Biên Hòa 6
Brussels 6
Columbus 6
Goiânia 6
Hải Dương 6
Nanchang 6
Ottawa 6
The Dalles 6
Tianjin 6
Verona 6
Blumenau 5
Bắc Ninh 5
Charlotte 5
Chattanooga 5
Des Moines 5
Faisalabad 5
Totale 4.257
Salva come PNG Salva come JPEG
Nome #
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 276
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 263
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 254
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 242
The role of adenosinergic system in brain ischemia 237
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 204
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 200
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 183
Development of novel pyridazinone-based adenosine receptor ligands 182
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 172
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 171
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 166
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 157
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 157
Adenosine and inflammation: Here, there and everywhere 152
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? 151
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 147
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives 145
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 144
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators 140
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease 138
Effect of Low-Frequency, Low-Energy Pulsed Electromagnetic Fields in Neuronal and Microglial Cells Injured with Amyloid-Beta 132
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes 132
Pharmacology of Adenosine Receptors: Recent Advancements 132
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 130
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? 129
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 127
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients 126
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation 124
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 124
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 123
Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications 122
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy 117
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 116
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 116
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 113
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy 111
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists 111
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 110
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy: a Preliminary Study 106
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 104
Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents 102
Pulsed electromagnetic fields stimulate hif-1α-independent vegf release in 1321n1 human astrocytes protecting neuron-like sh-sy5y cells from oxygen-glucose deprivation 96
Targeting adenosine receptors: A potential pharmacological avenue for acute and chronic pain 91
Piperazine-and piperidine-containing thiazolo[5,4-d]pyrimidine derivatives as new potent and selective adenosine a2a receptor inverse agonists 81
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 79
Cytotoxic and Antiproliferative Effects of [64Cu]CuCl2 in Tumor Cells for Radiometabolic Therapy 46
Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In Vivo 25
Totale 6.806
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022228 10 14 13 0 5 17 27 20 16 18 44 44
2022/2023286 29 48 4 27 23 20 43 22 24 9 23 14
2023/2024235 17 14 9 6 38 13 11 24 7 13 10 73
2024/20251.440 39 62 116 58 127 149 104 88 226 163 170 138
2025/20263.786 372 186 307 460 568 217 414 237 325 453 225 22
Totale 6.806